191 related articles for article (PubMed ID: 35941108)
21. MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression.
Sun Y; Jin X; Meng J; Guo F; Chen T; Zhao X; Wu H; Ren D
EMBO J; 2023 Dec; 42(23):e114558. PubMed ID: 37905571
[TBL] [Abstract][Full Text] [Related]
22. Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence.
Nissan MH; Pratilas CA; Jones AM; Ramirez R; Won H; Liu C; Tiwari S; Kong L; Hanrahan AJ; Yao Z; Merghoub T; Ribas A; Chapman PB; Yaeger R; Taylor BS; Schultz N; Berger MF; Rosen N; Solit DB
Cancer Res; 2014 Apr; 74(8):2340-50. PubMed ID: 24576830
[TBL] [Abstract][Full Text] [Related]
23. Spatial regulation of ARAF controls the MST2-Hippo pathway.
Rauch J; Kolch W
Small GTPases; 2019 Jul; 10(4):243-248. PubMed ID: 28281933
[TBL] [Abstract][Full Text] [Related]
24. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
[TBL] [Abstract][Full Text] [Related]
25. KIT Suppresses BRAF
Neiswender JV; Kortum RL; Bourque C; Kasheta M; Zon LI; Morrison DK; Ceol CJ
Cancer Res; 2017 Nov; 77(21):5820-5830. PubMed ID: 28947418
[TBL] [Abstract][Full Text] [Related]
26. Targeting oncogenic Raf protein-serine/threonine kinases in human cancers.
Roskoski R
Pharmacol Res; 2018 Sep; 135():239-258. PubMed ID: 30118796
[TBL] [Abstract][Full Text] [Related]
27. Regulating the response to targeted MEK inhibition in melanoma: enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation.
Conrad WH; Swift RD; Biechele TL; Kulikauskas RM; Moon RT; Chien AJ
Cell Cycle; 2012 Oct; 11(20):3724-30. PubMed ID: 22895053
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells.
Pardo OE; Lesay A; Arcaro A; Lopes R; Ng BL; Warne PH; McNeish IA; Tetley TD; Lemoine NR; Mehmet H; Seckl MJ; Downward J
Mol Cell Biol; 2003 Nov; 23(21):7600-10. PubMed ID: 14560006
[TBL] [Abstract][Full Text] [Related]
29. Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma.
Packer LM; East P; Reis-Filho JS; Marais R
Pigment Cell Melanoma Res; 2009 Dec; 22(6):785-98. PubMed ID: 19682280
[TBL] [Abstract][Full Text] [Related]
30. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
[TBL] [Abstract][Full Text] [Related]
31. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
Seidel C; Schagdarsurengin U; Blümke K; Würl P; Pfeifer GP; Hauptmann S; Taubert H; Dammann R
Mol Carcinog; 2007 Oct; 46(10):865-71. PubMed ID: 17538946
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of Smac by Akt promotes the caspase-3 activation during etoposide-induced apoptosis in HeLa cells.
Jeong CH; Chun KS; Kundu J; Park B
Mol Carcinog; 2015 Feb; 54(2):83-92. PubMed ID: 24038446
[TBL] [Abstract][Full Text] [Related]
33. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Ng CP; Bonavida B
Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
[TBL] [Abstract][Full Text] [Related]
34. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
[TBL] [Abstract][Full Text] [Related]
35. Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
Mohana-Kumaran N; Hill DS; Allen JD; Haass NK
Pigment Cell Melanoma Res; 2014 Jul; 27(4):525-39. PubMed ID: 24655414
[TBL] [Abstract][Full Text] [Related]
36. DNMT3B and TET1 mediated DNA methylation of LATS1 regulates BC progression via hippo signaling pathway.
Wu H; Jiao Y; Guo X; Wu Z; Lv Q
Pathol Res Pract; 2022 Dec; 240():154231. PubMed ID: 36413827
[TBL] [Abstract][Full Text] [Related]
37. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro.
MacFarlane M; Merrison W; Bratton SB; Cohen GM
J Biol Chem; 2002 Sep; 277(39):36611-6. PubMed ID: 12121969
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive split TEV based protein-protein interaction screening reveals TAOK2 as a key modulator of Hippo signalling to limit growth.
Ma X; Mandausch FJ; Wu Y; Sahoo VK; Ma W; Leoni G; Hostiuc M; Wintgens JP; Qiu J; Kannaiyan N; Rossner MJ; Wehr MC
Cell Signal; 2024 Jan; 113():110917. PubMed ID: 37813295
[TBL] [Abstract][Full Text] [Related]
39. Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling.
Romano D; Nguyen LK; Matallanas D; Halasz M; Doherty C; Kholodenko BN; Kolch W
Nat Cell Biol; 2014 Jul; 16(7):673-84. PubMed ID: 24929361
[TBL] [Abstract][Full Text] [Related]
40. Hippo pathway-dependent and -independent roles of RASSF6.
Ikeda M; Kawata A; Nishikawa M; Tateishi Y; Yamaguchi M; Nakagawa K; Hirabayashi S; Bao Y; Hidaka S; Hirata Y; Hata Y
Sci Signal; 2009 Sep; 2(90):ra59. PubMed ID: 19797269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
